The official news source for the International Symposium on Endovascular Therapy (ISET) providing information on the latest advancements in peripheral vascular disease treatment. | Read More

A novel device was able to prevent clinically significant pulmonary embolism (PE) and fatal PE in critically ill trauma patients. | Read More

Morristown Medical Center Randomizes First Patient in World to New Study to Evaluate Treatment for Asymptomatic Severe Aortic Stenosis | Read More

Joint Commission Compendium of Resources is Now Available to the Public for Free | Read More

Bothell, WA, 22 May 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the results of the OPTALYSE PE trial, presented at the American Thoracic Society International Conference in Washington, D.C. | Read More

Boston Scientific Corporation announced a definitive agreement to acquire Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices, for $435 million in up-fron | Read More

First U.S. Trial to Assess Delivery of a -Limus Agent to Prevent BTK Restenosis | Read More

BIOTRONIK’s Bare Metal Stent Proves Effective and Versatile as Standalone and in Combination with Drug-Coated Balloon in 12-Month Results of BIOFLEX PEACE and BIOLUX 4EVER   | Read More

PARIS - April 26, 2017—LimFlow SA, developer of minimally-invasive technology for the treatment of end-stage critical limb ischemia (CLI), a severe form of peripheral artery disease (PAD), announced today that the U.S. | Read More